Open AccessLY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancerviadeath receptor pathway
Author(s) -
Jie Liu
Publication year - 2011
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v17.i2.181
Subject(s) - oxaliplatin , fas ligand , protein kinase b , apoptosis , chemistry , programmed cell death , cancer research , ly294002 , cancer cell , pi3k/akt/mtor pathway , cell growth , pharmacology , microbiology and biotechnology , biology , medicine , cancer , biochemistry , colorectal cancer
To examine the effects of combined treatment of oxaliplatin and phosphatidylinositol 3'-kinase inhibitor, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) for gastric cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom